This inventor holds 1 USPTO granted patent. Top assignee: Seoul National University. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Doyeon Jo: Innovator in Antimicrobial Peptide Research
Introduction
Doyeon Jo is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of antimicrobial research, particularly focusing on peptides that exhibit activity against gram-negative bacteria. His innovative work has the potential to impact various applications in medicine and biotechnology.
Latest Patents
Doyeon Jo holds a patent for a "Broken or folded helical peptide or peptide analog exhibiting antimicrobial activity against gram-negative bacteria, and use thereof." This invention relates to a unique helical peptide or peptide analogue that possesses a kinked structure, enhancing its ability to penetrate gram-negative bacterial membranes. The patent also covers antimicrobial compositions that utilize the specific activity of this peptide, as well as conjugates that link drugs to the peptide or peptide analogue.
Career Highlights
Doyeon Jo is affiliated with Seoul National University, where he conducts his research and development in the field of antimicrobial peptides. His work is characterized by a strong focus on innovative solutions to combat bacterial infections, particularly those caused by gram-negative bacteria, which are known for their resistance to conventional antibiotics.
Collaborations
Doyeon Jo collaborates with notable colleagues, including Yan Lee and Seo Yeon Kim. These partnerships enhance the research efforts and contribute to the advancement of knowledge in the field of antimicrobial peptides.
Conclusion
Doyeon Jo's contributions to antimicrobial peptide research highlight his role as an innovator in the scientific community. His patented work on helical peptides showcases the potential for new therapeutic approaches to combat bacterial infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
